Azafaros Investors

22 investors on Angel Roster list Azafaros in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, Switzerland and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Azafaros can appear together.

Investors listed
22
With verified email
18%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 22 Azafaros investors

The most complete profiles first. Showing 22 of 22.

  • Alexander VosVerified

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Verified email available

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Diede Brunen

    Venture Capital, Private Equity Firm, Micro VC · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Edward Van Wezel

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Joost Holthuis

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Max Klement

    Venture Capital, Micro VC, Investor · United Kingdom

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Rob de Ree

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Kiran Dallenbach

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Stefan Fäs

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

Frequently asked questions

How many Azafaros investors are on Angel Roster?

Angel Roster lists 22 Azafaros investors. 4 of them (18%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (9) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Azafaros investors invest in?

Among those that list a stage, the most common are Seed (13) and Pre-Seed (6).

Where are Azafaros investors based?

Most are based in the Netherlands (17), Switzerland (2) and the United Kingdom (2).

Which companies have Azafaros investors backed?

The most-backed portfolio companies among them are NorthSea Therapeutics (20), Escalier Biosciences (20), arGEN-X (20), Dezima Pharma (20) and Hookipa Pharma (16).

How do I contact Azafaros investors?

Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.